Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ROPN1B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
mRNA | CTC-479C5.12 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
mRNA | INO80B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | NEDD8-MDP1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | ASB4 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
mRNA | ZFYVE28 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
mRNA | ALKBH6 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | IFI16 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | BCL2L12 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | CHST11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |